JP Morgan Chase
ACHC icon

JP Morgan Chase’s Acadia Healthcare ACHC Stock Holding History

JP Morgan Chase’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.13M Sell
93,240
-113,593
-55% -$2.06M ﹤0.01% 4056
2025
Q4 		$2.93M Buy
206,833
+3,175
+2% +$60.1K ﹤0.01% 3782
2025
Q3 		$5.04M Buy
203,658
+37,107
+22% +$828K ﹤0.01% 3353
2025
Q2 		$3.78M Sell
166,551
-752,075
-82% -$17.8M ﹤0.01% 3407
2025
Q1 		$27.9M Buy
918,626
+102,417
+13% +$3.9M ﹤0.01% 1662
2024
Q4 		$32.4M Sell
816,209
-2,310,398
-74% -$104M ﹤0.01% 1604
2024
Q3 		$198M Buy
3,126,607
+454,044
+17% +$32.8M 0.02% 689
2024
Q2 		$181M Sell
2,672,563
-175,530
-6% -$12.3M 0.01% 694
2024
Q1 		$226M Sell
2,848,093
-310,816
-10% -$25.4M 0.02% 613
2023
Q4 		$246M Sell
3,158,909
-75,526
-2% -$5.59M 0.02% 559
2023
Q3 		$227M Sell
3,234,435
-127,099
-4% -$9.5M 0.03% 520
2023
Q2 		$268M Buy
3,361,534
+15,177
+0.5% +$1.1M 0.03% 479
2023
Q1 		$242M Sell
3,346,357
-289,665
-8% -$22.6M 0.03% 494
2022
Q4 		$299M Sell
3,636,022
-411,349
-10% -$33.9M 0.04% 402
2022
Q3 		$316M Buy
4,047,371
+20,995
+0.5% +$1.68M 0.05% 372
2022
Q2 		$272M Buy
4,026,376
+360
+0% +$25.1K 0.04% 418
2022
Q1 		$264M Buy
4,026,016
+12,583
+0.3% +$731K 0.03% 477
2021
Q4 		$244M Sell
4,013,433
-1,445
-0% -$86.2K 0.03% 510
2021
Q3 		$256M Sell
4,014,878
-391,222
-9% -$24.7M 0.03% 506
2021
Q2 		$276M Buy
4,406,100
+380,515
+9% +$23.9M 0.03% 506
2021
Q1 		$230M Buy
4,025,585
+412,221
+11% +$22.3M 0.03% 530
2020
Q4 		$182M Buy
3,613,364
+34,343
+1% +$1.37M 0.03% 563
2020
Q3 		$101M Buy
3,579,021
+191,193
+6% +$5.55M 0.02% 693
2020
Q2 		$85.1M Sell
3,387,828
-1,634,408
-33% -$40.8M 0.02% 705
2020
Q1 		$92.2M Sell
5,022,236
-134,140
-3% -$3.84M 0.02% 590
2019
Q4 		$171M Sell
5,156,376
-181,542
-3% -$5.69M 0.03% 482
2019
Q3 		$166M Buy
5,337,918
+468,893
+10% +$14.3M 0.03% 491
2019
Q2 		$167M Buy
4,869,025
+192,154
+4% +$6.21M 0.03% 504
2019
Q1 		$137M Buy
4,676,871
+52,097
+1% +$1.48M 0.03% 550
2018
Q4 		$119M Sell
4,624,774
-1,408,592
-23% -$48.8M 0.03% 562
2018
Q3 		$212M Buy
6,033,366
+204,401
+4% +$8.14M 0.04% 441
2018
Q2 		$238M Sell
5,828,965
-794,870
-12% -$32.1M 0.05% 392
2018
Q1 		$260M Sell
6,623,835
-585,304
-8% -$21.5M 0.06% 350
2017
Q4 		$235M Buy
7,209,139
+391,883
+6% +$13.6M 0.05% 388
2017
Q3 		$323M Sell
6,817,256
-89,943
-1% -$4.38M 0.07% 286
2017
Q2 		$341M Sell
6,907,199
-798,776
-10% -$35.4M 0.08% 268
2017
Q1 		$336M Buy
7,705,975
+59,735
+0.8% +$2.42M 0.08% 263
2016
Q4 		$253M Buy
7,646,240
+1,638,048
+27% +$63.6M 0.06% 323
2016
Q3 		$298M Buy
6,008,192
+1,008,466
+20% +$52.5M 0.07% 283
2016
Q2 		$277M Buy
4,999,726
+251,179
+5% +$14.7M 0.07% 301
2016
Q1 		$262M Buy
4,748,547
+715,472
+18% +$40.8M 0.07% 312
2015
Q4 		$252M Buy
4,033,075
+328,978
+9% +$21.4M 0.06% 321
2015
Q3 		$245M Sell
3,704,097
-257,461
-6% -$19.8M 0.07% 303
2015
Q2 		$310M Buy
3,961,558
+429,164
+12% +$30.9M 0.07% 298
2015
Q1 		$253M Buy
3,532,394
+78,386
+2% +$5.03M 0.06% 358
2014
Q4 		$211M Buy
3,454,008
+1,133,994
+49% +$66M 0.05% 396
2014
Q3 		$113M Sell
2,320,014
-70,935
-3% -$3.47M 0.03% 576
2014
Q2 		$109M Buy
2,390,949
+430,710
+22% +$18.9M 0.03% 547
2014
Q1 		$88.4M Sell
1,960,239
-15,075
-0.8% -$744K 0.02% 586
2013
Q4 		$93.5M Sell
1,975,314
-500,585
-20% -$21.8M 0.03% 550
2013
Q3 		$97.6M Sell
2,475,899
-490,442
-17% -$18.2M 0.03% 545
2013
Q2 		$98.1M Buy
+2,966,341
New +$96.3M 0.03% 512

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase's ACHC Position: Q1 2026 in Review

JP Morgan Chase reduced its Acadia Healthcare (ACHC) stake by 55% in Q1 2026, selling an estimated $2.06M and leaving 93,240 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #4056.

JP Morgan Chase first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $341M in Q2 2017. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • JP Morgan Chase held 93,240 shares of Acadia Healthcare worth $2.13M as of Q1 2026.
  • JP Morgan Chase sold 113,593 Acadia Healthcare shares in Q1 2026, an estimated $2.06M.
  • Acadia Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4056 holding.
  • JP Morgan Chase first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Acadia Healthcare position peaked at $341M in Q2 2017.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.